Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2016-5820
2. Registrant Information.
Registrant Reference Number: 2016-IR-07
Registrant Name (Full Legal Name no abbreviations): E.I. du Pont Canada Company
Address: 1919 Minnesota Court
City: Mississauga
Prov / State: ON
Country: Canada
Postal Code: L5M 2J4
3. Select the appropriate subform(s) for the incident.
Scientific Study
4. Date registrant was first informed of the incident.
5. Location of incident.
6. Date incident was first observed.
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 30890
PMRA Submission No.
EPA Registration No. 352-856
Product Name: DuPont Cyazypr Technical Insecticide
7. b) Type of formulation.
Granular
Dry Flowable (water dispersible granules)
Application Information
8. Product was applied?
Unknown
9. Application Rate.
10. Site pesticide was applied to (select all that apply).
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform VII: Scientific Study
1. Study Reference
Title IN-M2G98: Repeated-Dose Oral Toxicity 28-Day Feeding Study in Rats
Date 31-AUG-16
2. a) Is an extension needed to translate the document?
No
3. Type of incident identified in the study
Presence of a component or derivitive
4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)
We have recently conducted two (2) toxicity studies in rats: 1) an acute oral (Up-and-Down Method), and, 2) a 28-day repeated dose; with IN-M2G98, a minor (detected at less than 1% of parent) metabolite/degradate of DuPont Cyazypyr Technical, EPA Reg. No. 352-856, PCP#30890. These studies were required by EFSA as a component to the European submission for Cyantraniliprole.
5. a) Was the study discontinued before completion?
No
5. b) Provide the reason for discontinuation
6. If the study is ongoing, what is the expected completion date?
For Registrant use only
7. Provide supplemental information here
These studies were required by EFSA as a component to the European submission for Cyantraniliprole.